HIV-1-induced pulmonary oxidative and nitrosative stress: Exacerbated response to endotoxin administration in HIV-1 transgenic mouse model

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 291, Issue 4, 2006, Pages

  Jacob, Barbara A ^a   Porter, Kristi M ^a   Elms, Shawn C ^a   Cheng, Po Yung ^a   Jones, Dean P ^a   Sutliff, Roy L ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Glutathione; Human immunodeficiency virus transgenic mice; Hydrogen peroxide; Nitrosoglutathione; Nitrotyrosine; Superoxide

Indexed keywords

3 NITROTYROSINE; CYTOKINE; DRUG METABOLITE; ENDOTOXIN; GLUTATHIONE; HYDROGEN PEROXIDE; LIPOPOLYSACCHARIDE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE FUNCTION TEST; LUNG EDEMA; LUNG FUNCTION; LUNG LAVAGE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; TRANSGENIC ANIMAL;

ANIMALS; CYTOKINES; GLUTATHIONE; HIV INFECTIONS; HIV-1; HYDROGEN PEROXIDE; LIPOPOLYSACCHARIDES; LUNG; MICE; MICE, TRANSGENIC; NITRATES; NITRITES; NITROSATION; OXIDATIVE STRESS; PULMONARY EDEMA; TYROSINE;

EID: 33749333588     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00468.2005     Document Type: Article

References (47)

1. Abramczuk JW, Pezen DS, Leonard JM, Monell-Torrens E, Belcher JH, Martin MA, and Notkins AL. Transgenic mice carrying intact HIV provirus: biological effects and organization of a transgene. J Acquir Immune Defic Syndr 5: 196-203, 1992.
2. Afessa B, Green W, Chiao J, and Frederick W. Pulmonary complications of HIV infection. Chest 113: 1225-1229, 1998.
3. Andreadis AA, Hazen SL, Comhair SA, and Erzurum SC. Oxidative and nitrosative events in asthma. Free Radic Biol Med 35: 213-225, 2003.
4. Bowler RP, Arcaroli J, Crapo JD, Ross A, Slot JW, and Abraham E. Extracellular superoxide dismutase attenuates lung injury after hemorrhage. Am J Respir Crit Care Med 164: 290-294, 2001.
5. Boyton RJ. Infectious lung complications in patients with HIV/AIDS. Curr Opin Pulm Med 11: 203-207, 2005.
6. Brown LAS, Harris FL, and Guidot DM. Chronic ethanol ingestion potentiates TNF-α mediated oxidative stress and apoptosis in rat alveolar type II cells. Am J Physiol: Lung Cell Mol Physiol 281: L377-L386, 2001.
7. Brown LAS, Harris FL, Bechara R, and Guidot DM. Effect of chronic ethanol ingestion on alveolar type II cell glutathione and inflammatory mediator-induced apoptosis. Alcoholism: Clin Exp Res 27: 1078-1085, 2001.
8. Bruggeman LA, Thomson M, Nelson PJ, Kopp JB, Rappaport J, Klotman PE, and Klotman ME. Patterns of HIV-1 mRNA expression in transgenic mice are tissue-dependent. Virology 202: 940-948, 1994.
9. Buhl R, Jaffe HA, Holroyd KJ, Wells FB, Mastrangeli A, Saltini C, Cantin AM, and Crystal RG. Systemic glutathione deficiency in symptom-free HIV seropositive individuals. Lancet 2: 1294-1298, 1989.
10. Choi J, Liu RM, Kundu RK, Sangiorgi F, Wu W, Maxson R, and Forman HJ. Molecular mechanism of decreased glutathione content in human immunodeficiency virus type 1 Tat-transgenic mice. J Biol Chem 275: 3693-3698, 2000.
11. Cohen I, Boya P, Zhao L, Metivier D, Andreau K, Perfettini JL, Weaver JG, Badley A, Taylor EW, and Kroemer G. Anti-apoptotic activity of the glutathione peroxidase homologue encoded by HIV-1. Apoptosis 9: 181-192, 2004.
12. Demarchi F, d'Adda di Fagagna F, Falaschi A, and Giacca M. Activation of transcription factor NF-kappa B by the Tat protein of human immunodeficiency virus type 1. J Virol 70: 4427-4437, 1996.
13. Diamond AM, Hu YJ, and Mansur DB. Glutathione peroxidase and viral replication: implications for viral evolution and chemoprevention. Biofactors 14: 205-210, 2001.
14. Dickie P, Felser J, Eckhaus M, Bryant J, Silver J, Marinos N, and Notkins AL. HIV-associated nephropathy in transgenic mice expressing HIV-1 genes. Virology 185: 109-119, 1991.
15. Droege W. Cysteine and glutathione deficiency in AIDS patients: a rationale for the treatment with N-acetyl-cysteine. Pharmacology 46: 61-65, 1993.
16. Flores SC, Marecki JC, Harper KP, Bose SK, Nelson SK, and McCord JM. Tat protein of human immunodeficiency virus type 1 represses expression of manganese superoxide dismutase in HeLa cells. Proc Natl Acad Sci USA 90: 7632-7636, 1993.
17. Gil L, Martinez G, Gonzalez I, Tarinas A, Alvarez A, Giuliani A, Molina R, Tapanes R, Perez J, and Leon OS. Contribution to characterization of oxidative stress in HIV/AIDS patients. Pharmacol Res 47: 217-224, 2003.
18. Gras-Le Guen C, Jarry A, Vallette G, Toquet C, Colombeix C, Laboisse CL, Potel G, Roze JC, Bugnon D, and Debillon T. Antibiotic therapy reduces nitrosative stress and programmed cell death in the rabbit fetal lung. Eur Respir J 25: 88-95, 2005.
19. Gulow K, Kaminski M, Darvas K, Suss D, Li-Weber M, and Krammer P. HIV-1 trans-activator of transcription substitutes for oxidative signaling in activation-induced T cell death. J Immunol 174: 5249-5260, 2005.
20. Halestrap AP and Brennerb C. The adenine nucleotide translocase: a central component of the mitochondrial permeability transition pore and key player in cell death. Curr Med Chem 10: 1507-1525, 2003.
21. Hamilos DL, Zelarney P, and Mascali JJ. Lymphocyte proliferation in glutathione-depleted lymphocytes: direct relationship between glutathione availability and the proliferative response. Immunopharmacology 18: 223-235, 1989.
22. Hirschtick RE, Glassroth J, Jordan MC, Wilcosky TC, Wallace JM, Kvale PA, Markowitz N, Rosen MJ, Mangura BT, and Hopewell PC. Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group. N Engl J Med 333: 845-851, 1995.
23. Hung CC and Chang SC. Impact of highly active antiretroviral therapy on incidence and management of human immunodeficiency virus-related opportunistic infections. J Antimicrob Chemother 54: 849-853, 2004.
24. Iwata S, Hori T, Sato N, Ueda-Taniguchi Y, Yamabe T, Nakamura H, Masutani H, and Yodoi J. Thiol-mediated redox regulation of lymphocyte proliferation. Possible involvement of adult T cell leukemia-derived factor and glutathione in transferrin receptor expression. J Immunol 152: 5633-5642, 1994.
25. Jones DP. Redox potential of GSH/GSSG couple: assay and biological significance. Methods Enzymol 348: 93-112, 2002.
26. Kanmogne GD, Kennedy RC, and Grammas P. Analysis of human lung endothelial cells for susceptibility to HIV type 1 infection, coreceptor expression and cytotoxicity of gp 120 protein. AIDS Res Hum Retroviruses 17: 45-53, 2001.
27. Kanmogne GD, Primeaux C, and Grammas P. Induction of apoptosis and endothelin-1 secretion in primary human lung endothelial cells by HIV-1 gp 120 proteins. Biochem Biophys Res Commun 333: 1107-1115, 2005.
28. Kedzierska K, Azzam R, Ellery P, Mak J, Jaworowski A, and Crowe SM. Defective phagocytosis by human monocyte/macrophages following HIV-1 infection: underlying mechanisms and modulation by adjunctive cytokine therapy. J Clin Virol 26: 247-263, 2003.
29. Kharitonov SA and Barnes PJ. Nitric oxide, nitrotyrosine, and nitric oxide modulators in asthma and chronic obstructive pulmonary disease. Curr Allergy Asthma Rep 3: 121-129, 2003.
30. Leonard MK, Larsen N, Drechsler H, Blumberg H, Lennox JL, Arrellano M, Filip J, and Horsburgh CR Jr. Increased survival of persons with tuberculosis and human immunodeficiency virus infection, 1991-2000. Clin Infect Dis 34: 1002-1007, 2002.
31. Levy EM, Wu J, Salibian M, and Black PH. The effect of changes in thiol subcompartments on T-cell colony formation and cell cycle progression. Cell Immunol 140: 370-380, 1992.
32. Maly FE. The B lymphocyte: a newly recognized source of reactive oxygen species with immunoregulatory potential. Free Radic Res Commun 8: 143-148, 1990.
33. Olubajo B and Taylor EW. A-1 frameshift in the HIV-1 env gene is enhanced by arginine deficiency via a hungry codon mechanism. Mutat Res 579: 125-132, 2005.
34. Pace GW and Leaf CD. The role of oxidative stress in HIV disease. Free Radic Biol Med 19: 523-528, 1995.
35. Price TO, Ercal N, Nakaoke R, and Banks WA. HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells. Brain Res 1045: 57-63, 2005.
36. Ricciardolo FL, Sterk PJ, Gaston B, and Folkerts G. Nitric oxide in health and disease of the respiratory system. Physiol Rev 84: 731-765, 2004.
37. Rojas M, Woods CR, Mora AL, Xu J, and Brigham KL. Endotoxin-induced lung injury in mice: structural, functional, and biochemical responses. Am J Physiol Lung Cell Mol Physiol 288: L333-L341, 2005.
38. Saluk-Juszczak J, Wachowicz B, Bald E, and Gowacki R. Effects of lipopolysaccharides from gram-negative bacteria on the levels of thiols in blood platelets. Curr Microbiol 51: 153-155, 2005.
39. Stebbing J, Gazzard B, and Douek DC. Where does HIV live? N Engl J Med 350: 1872-1880, 2004.
40. Taylor EW, Cox AG, Zhao L, Ruzicka JA, Bhat AA, Zhang W, Nadimpalli RG, and Dean RG. Nutrition, HIV, and drug abuse: the molecular basis of a unique role for selenium. J Acquir Immune Defic Syndr 25, Suppl: S53-S61, 2000.
41. Touloumi G, Hatzakis A, Potouridou I, Milona I, Strarigos J, Katsambas A, Giraldo G, Beth-Giraldo E, Biggar RJ, Mueller N, and Trichopoulos D. The role of immunosuppression and immune-activation in classic Kaposi's sarcoma. Int J Cancer 82: 817-821, 1999.
42. Treitinger A, Spada C, Verdi JC, Miranda AF, Oliveira OV, Silveira MV, Moriel P, and Abdalla DS. Decreased antioxidant defence in individuals infected by the human immunodeficiency virus. Eur J Clin Invest 30: 454-459, 2000.
43. Villa P, Saccani A, Sica A, and Ghezzi P. Glutathione protects mice from lethal sepsis by limiting inflammation and potentiating host defense. J Infect Dis 15: 185, 2002.
44. Walsh KA, Megyesi J, Wilson JX, Crukley J, Laubach VE, and Hammond RR. Antioxidant protection from HIV-1 gp 120-induced neuroglial toxicity. J Neuroinflammation 1: 8, 2004.
45. Wink DA and Mitchell JB. Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic Biol Med 25: 434-456, 1998.
46. Zhang H, Boring D, and Haverkos H. Human-bacteria nitric oxide cycles in HIV-1 infection. Med Hypotheses 58: 439-443, 2002.
47. Zhao L, Cox AG, Ruzicka JA, Bhat AA, Zhang W, and Taylor EW. Molecular modeling and in vitro activity of an HIV-1-encoded glutathione peroxidase. Proc Natl Acad Sci USA 97: 6356-6361, 2000.